Insider Trading - iTeos Therapeutics Inc. (ITOS)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for iTeos Therapeutics Inc.
Goto 0, 1, 2, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-09-09
Sale
2021-09-13
6:59 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
57,640 $28.32 $1,632,261 3,534,241
(Indirect)
View
2021-09-09
Sale
2021-09-13
7:01 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
57,640 $28.32 $1,632,261 3,534,241
(Indirect)
View
2021-09-09
Sale
2021-09-13
7:02 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
96,456 $28.32 $2,731,460 5,805,340
(Indirect)
View
2021-09-14
Sale
2021-09-16
4:46 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
76,417 $27.7 $2,116,733 5,728,923
(Indirect)
View
2021-09-14
Sale
2021-09-16
4:46 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
45,665 $27.7 $1,264,910 3,488,576
(Indirect)
View
2021-09-14
Sale
2021-09-16
4:48 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
45,665 $27.7 $1,264,910 3,488,576
(Indirect)
View
2021-09-16
Sale
2021-09-20
6:30 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
152,711 $28.38 $4,334,452 5,576,212
(Indirect)
View
2021-09-16
Sale
2021-09-20
6:37 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
91,254 $28.38 $2,590,097 3,397,322
(Indirect)
View
2021-09-16
Sale
2021-09-20
6:38 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
91,254 $28.38 $2,590,097 3,397,322
(Indirect)
View
2021-09-21
Sale
2021-09-23
4:18 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
56,779 $27.5 $1,561,394 5,519,433
(Indirect)
View
2021-09-21
Sale
2021-09-23
4:19 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
33,929 $27.5 $933,030 3,363,393
(Indirect)
View
2021-09-21
Sale
2021-09-23
4:19 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
33,929 $27.5 $933,030 3,363,393
(Indirect)
View
2021-09-23
Sale
2021-09-27
5:51 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
89,476 $27.76 $2,484,094 5,429,957
(Indirect)
View
2021-09-23
Sale
2021-09-27
5:51 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
53,468 $27.76 $1,484,416 3,309,925
(Indirect)
View
2021-09-23
Sale
2021-09-27
5:52 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
53,468 $27.76 $1,484,416 3,309,925
(Indirect)
View
2021-09-23
Sale
2021-09-27
8:00 pm
iTeos Therapeutics Inc. ITOS Detheux Michel
CEO
6,411 $28.14 $180,374 99,026
(Direct)
View
2021-09-28
Sale
2021-09-30
5:05 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
35,990 $27 $971,730 5,393,967
(Indirect)
View
2021-09-28
Sale
2021-09-30
5:06 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
21,506 $27 $580,662 3,288,419
(Indirect)
View
2021-09-28
Sale
2021-09-30
5:06 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
21,506 $27 $580,662 3,288,419
(Indirect)
View
2021-10-01
Sale
2021-10-05
4:31 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
46,130 $27.05 $1,247,590 5,347,837
(Indirect)
View
2021-10-01
Sale
2021-10-05
4:32 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
27,566 $27.05 $745,525 3,260,853
(Indirect)
View
2021-10-01
Sale
2021-10-05
4:33 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
27,566 $27.05 $745,525 3,260,853
(Indirect)
View
2021-10-07
Sale
2021-10-12
4:33 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
87,006 $27.23 $2,368,800 5,260,831
(Indirect)
View
2021-10-07
Sale
2021-10-12
4:34 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
51,993 $27.23 $1,415,546 3,208,860
(Indirect)
View
2021-10-07
Sale
2021-10-12
4:34 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
51,993 $27.23 $1,415,546 3,208,860
(Indirect)
View
2021-10-12
Sale
2021-10-14
5:26 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
95,002 $27.21 $2,584,606 5,165,829
(Indirect)
View
2021-10-12
Sale
2021-10-14
5:27 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
56,770 $27.21 $1,544,474 3,152,090
(Indirect)
View
2021-10-12
Sale
2021-10-14
5:28 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
56,770 $27.21 $1,544,474 3,152,090
(Indirect)
View
2021-10-15
Sale
2021-10-18
4:33 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
28,615 $27.45 $785,384 5,137,214
(Indirect)
View
2021-10-15
Sale
2021-10-18
4:34 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
17,099 $27.45 $469,309 3,134,991
(Indirect)
View
2021-10-15
Sale
2021-10-18
4:35 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
17,099 $27.45 $469,309 3,134,991
(Indirect)
View
2021-10-15
Sale
2021-10-19
8:01 pm
iTeos Therapeutics Inc. ITOS Detheux Michel
CEO
1,836 $28.01 $51,424 97,190
(Direct)
View
2021-10-21
Sale
2021-10-25
8:00 pm
iTeos Therapeutics Inc. ITOS Detheux Michel
CEO
196 $28 $5,488 96,994
(Direct)
View
2021-11-01
Sale
2021-11-03
7:59 pm
iTeos Therapeutics Inc. ITOS Detheux Michel
CEO
20,557 $28.55 $586,966 76,437
(Direct)
View
2021-11-18
Sale
2021-11-19
8:00 pm
iTeos Therapeutics Inc. ITOS Lager Joanne Jenkins
Chief Medical Officer
28,000 $34.5 $966,000 206,938
(Direct)
View
2021-11-17
Sale
2021-11-24
6:34 pm
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
77,455 $36.61 $2,835,263 3,057,536
(Indirect)
View
2021-11-17
Sale
2021-11-24
6:35 pm
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
77,455 $36.61 $2,835,263 3,057,536
(Indirect)
View
2021-11-17
Sale
2021-11-24
6:38 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
129,617 $36.61 $4,744,666 5,007,597
(Indirect)
View
2021-11-22
Sale
2021-11-24
7:59 pm
iTeos Therapeutics Inc. ITOS Detheux Michel
CEO
14,500 $36.08 $523,160 78,200
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-10-11
Exercise
2021-10-12
8:02 pm
N/A
2030-06-18
iTeos Therapeutics Inc. ITOS Gall Matthew
CFO
14,429 $0 61,817
(Direct)
View
2021-10-11
Exercise
2021-10-12
8:02 pm
N/A
N/A
iTeos Therapeutics Inc. ITOS Gall Matthew
CFO
14,429 $6.16 61,817
(Direct)
View
2021-11-18
Exercise
2021-11-19
8:00 pm
N/A
2025-06-11
iTeos Therapeutics Inc. ITOS Lager Joanne Jenkins
Chief Medical Officer
28,000 $0 206,938
(Direct)
View
2021-11-18
Exercise
2021-11-19
8:00 pm
N/A
N/A
iTeos Therapeutics Inc. ITOS Lager Joanne Jenkins
Chief Medical Officer
28,000 $4.3 206,938
(Direct)
View
2021-11-17
Other
2021-11-24
6:34 pm
N/A
N/A
iTeos Therapeutics Inc. ITOS MPM BioVentures 2014 L.P.
EVNIN LUKE
Foley Todd
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
15,671 $0 3,057,536
(Indirect)
View
2021-11-17
Other
2021-11-24
6:35 pm
N/A
N/A
iTeos Therapeutics Inc. ITOS MPM BIOVENTURES 2018 L.P.
MPM BioVentures 2018 LLC
MPM BioVentures 2018 GP LLC
10% Owner
15,671 $0 3,057,536
(Indirect)
View
2021-11-17
Other
2021-11-24
6:38 pm
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
15,671 $0 5,007,597
(Indirect)
View
2021-11-22
Exercise
2021-11-24
7:59 pm
2015-11-13
2021-12-16
iTeos Therapeutics Inc. ITOS Detheux Michel
CEO
16,263 $0 78,200
(Direct)
View
2021-11-22
Exercise
2021-11-24
7:59 pm
N/A
N/A
iTeos Therapeutics Inc. ITOS Detheux Michel
CEO
16,263 $12.45 78,200
(Direct)
View
Goto 0, 1, 2, Next